Research Article
Cladribine Treatment Improved Homocysteine Metabolism and Increased Total Serum Antioxidant Activity in Secondary Progressive Multiple Sclerosis Patients
Figure 1
Homocysteine level before (Hcy1) and after (Hcy2) cladribine treatment in SP-MS patients; .